Zhao Hong

Mr. Zhao Hong


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2016 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
JLJianlong Li
Jianlong Li
JCJinquan Cai
Jinquan Cai
ZHZhao Hong
Zhao Hong
KYKun Yao
Kun Yao
YSYing Sun
Ying Sun
CJchuanlu jiang
chuanlu jiang
The aim of this study was to investigate the effect of downregulating Hedgehog pathway by GANT61 on human glioma cells, examine the consequent changes of temozolomide (TMZ)-induced effects and explore the molecular mechanisms. The cytotoxicity of a Gli1/2 inhibitor, GANT61 was examined both alone and in combination with TMZ in human glioma cell lines. The mRNA and protein expression alterations were determined by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot, respectively. CCK-8 assay detected the cell proliferative capability. Apoptotic cell number was measured by flow cytometry. The transwell assay was used to test the cell invasive capability. DNA damage effect was identified by COMET assay and γH2AX expression. Proliferation of tumor cells treated with GANT61 in combination with TMZ was significantly suppressed compared with those treated with either drug used alone. The combination treatment induced a higher rate of apoptosis, DNA damage and reduced the invasive capability of glioma cells. DNA damage repair enzyme MGMT and the Notch1 pathway increased in the cells treated by TMZ treatment. However, GANT61 could abrogated the protein increasing. GANT61 sensitizes glioma cells to TMZ treatment by enhancing DNA damage effect, decreasing MGMT expression and the Notch1 pathway.

10 June 2024 in Nursing Open
Verified
Journal Article
Open access
LLLei Li
Lei Li
JFJing Fan
Jing Fan
LQLili Qiu
Lili Qiu
CLChunyan Li
Chunyan Li
XHXuanye Han
Xuanye Han
YWYing Wang
Ying Wang
Aim: Many people see nursing as a high‐pressure, high‐risk profession. Therefore, job burnout among nursing staff has become an important topic of study and has received widespread attention worldwide. This research intended to evaluate the frequency of and variables related with work burnout among nurses in public hospitals in China.Design: Using a multistage random sample procedure, a cross‐sectional survey was carried out in the eastern, central and western areas of China.Methods: The Maslach Inventory‐Human Service Survey and demographic information made up the two sections of the questionnaire. Of the 5250 questionnaires sent, 4865 were deemed legitimate, yielding an effective response rate of 92.67%. A linear regression analysis was performed to investigate the variables linked to nursing work burnout.Results: Among the 4865 nurses, women accounted for 97.4% of the survey respondents, most of whom were aged 26–35 years. Results showed that the total scores of emotional exhaustion (EE), depersonalization (DP) and reduced personal accomplishment (PA) were 20.02 ± 12.04, 4.78 ± 5.54 and 34.42 ± 10.32 respectively. 50.7% of subjects obtained high or moderated scores on EE, 32.8% of subjects obtained high or moderated scores on DP and 80.4% of subjects obtained low or moderated scores on PA. Age, department, position, post‐establishment, work shift type in recent months, overtime times in recent months and night shift frequency in recent months were negatively correlated with EE, and child status, monthly income, working days per week and sleep quality in recent 1 month were positively correlated with it (F = 141.827, P < 0.01, R2 = 0.243). Age, gender, department, post‐establishment, overtime hours in recent months and night shift frequency in recent months were negatively correlated with DP, and child status and sleep quality in the last 1 month were positively correlated with it (F = 78.794, p < 0.01, R2 = 0.115). Child status, years of nursing work and sleep quality in the last 1 month were negatively correlated with PA, whereas age, position, work shift type in recent months and night shift frequency in recent months were positively correlated with it (F = 67.981, p < 0.01, R2 = 0.089).

Verified
Journal Article
Open access
PDF file
YSYing Sun
Ying Sun
YTYu Tian
Yu Tian
GWGuang-Zhi Wang
Guang-Zhi Wang
ZHZhao Hong
Zhao Hong
BHBo Han
Bo Han
CJChuanlu Jiang
Chuanlu Jiang
Gliomas are malignant primary brain tumors with poor prognosis. Recently, research was indicative of a tight connection between tumor malignancy and genetic alterations. Here, we propose an oncogenic implication of transforming acidic coiled-coil-containing protein 3 (TACC3) in gliomas. By comprehensively analyzing the Chinese glioma genome atlas (CGGA) and publicly available data, we demonstrated that TACC3 were overexpressed along with glioma grade and served as an independent negative prognostic biomarker for glioma patients. Functions’ annotations and gene sets’ enrichment analysis suggested that TACC3 may participate in cell cycle, DNA repair, epithelium-mesenchymal transition and other tumor-related biological processes and molecular pathways. Patients with high TACC3 expression showed CD133+ stem cell properties, glioma plasticity and shorter overall survival time under chemo-/radio-therapy. Additionally, a TACC3 associated the miRNA-mRNA network was constructed based on in silico prediction and expression pattern, which provide a foundation for further detection of TACC3-miRNA-mRNA axis function. Collectively, our observations identify TACC3 as an oncogene of tumor malignancy, as well as a prognostic and motoring biomarker for glioma patients.

1 September 2025 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
STShasha Tang
Shasha Tang
ZHZhao Hong
Zhao Hong
Objective: To analyze the current application status, technical characteristics, and challenges of Generative Artificial Intelligence (Generative AI) in perinatal health care for advanced maternal age pregnant women and explore targeted optimization strategies. Methods: A systematic literature review was conducted by searching PubMed, Web of Science, CNKI, and Wanfang Data from January 2020 to April 2025. Studies were included if they focused on Generative AI applications in perinatal care for women aged ≥ 35 years; 78 eligible studies (42 Chinese, 36 international) were finally included, covering technical applications, clinical validation, and ethical governance. We summarized the applications of Generative AI in risk prediction, personalized management, and remote monitoring, and analyzed issues related to data governance, technical limitations, resource allocation, and ethical supervision. Results: Generative AI improves healthcare efficiency by integrating multiple data sources for model construction, planning dynamic interventions, and facilitating remote monitoring. Specifically, GANs-based models achieve an AUC of 0.80– 0.85 in predicting Group B Streptococcus infection, while Transformer models enhance the accuracy of prenatal depression screening by 15– 20% compared to traditional methods. However, it faces challenges including data privacy risks (eg, 32% of maternal health institutions lack encrypted data storage), the “black box” nature of models (42% of clinicians report low trust in AI decision-making), urban-rural technological gaps (only 18% of county-level hospitals use AI perinatal tools), and ambiguous liability definitions. Conclusion: Generative AI demonstrates significant application potential in perinatal care for advanced maternal age pregnant women. Promoting its implementation through technological innovation (eg, explainable AI), interpretability optimization, resource deployment (eg, lightweight mobile tools), and ethical supervision is crucial to improving maternal and infant health outcomes in China and globally. Plain Language Summary: As more women delay pregnancy until age 35 or older (advanced maternal age), they face higher risks of complications like gestational diabetes and preterm birth—risks traditional healthcare struggles to address with personalized, round-the-clock care. This review explores how Generative AI (technology that analyzes data to generate new insights) could transform care for this group. We searched 4 international and Chinese databases (2020– 2025) and analyzed 78 studies. We found Generative AI can: Predict risks early: Use medical records and real-time data to spot issues like infections or depression before they worsen (eg, AI models correctly identify 80% of Group B Streptococcus cases by 35 weeks of gestation); Create tailored plans: Design personalized nutrition, exercise, and mental health strategies based on each woman’s needs (eg, AI nutritional interventions reduce gestational diabetes-related macrosomia by 22%); Monitor remotely: Use wearable devices to track vital signs and alert doctors to emergencies—especially helpful in rural areas where healthcare resources are limited. However, challenges remain: Patient data is not always secure, doctors often do not understand how AI makes decisions, rural hospitals rarely have access to AI tools, and no clear rules exist for who is responsible if AI makes a mistake. Our findings mean that with better data protection, transparent AI algorithms, and fair access to technology, Generative AI could make high-quality perinatal care more accessible—helping advanced maternal age women have healthier pregnancies and babies, both in China and around the world.